摘要

关键词：
• I型单纯疱疹病毒（HSV-1）
• , F毒株
• , 合成生物学
• , Cre-LoxP重组技术

Abstract

References

1. Demir S, Tastan C, Ulu ZO, Canbaz EN, Unlen L, Sahin F. 2024. Comparison of strain specific pathogenicity of herpes simplex virus type 1 by high-throughput sequencing. J Virol Methods, 329: 114994.
   

2. Dix RD, McKendall RR, Baringer JR. 1983. Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of balb/c mice. Infect Immun, 40: 103-112.
   

3. Dotto-Maurel A, Arzul I, Morga B, Chevignon G. 2025. Herpesviruses: Overview of systematics, genomic complexity and life cycle. Virol J, 22: 155.
   

4. Frampton JE. 2022. Teserpaturev/g47δ: First approval. BioDrugs, 36: 667-672.
   

5. Gierasch WW, Zimmerman DL, Ward SL, Vanheyningen TK, Romine JD, Leib DA. 2006. Construction and characterization of bacterial artificial chromosomes containing hsv-1 strains 17 and kos. J Virol Methods, 135: 197-206.
   

6. Grzesik P, Ko N, Oldfield LM, Vashee S, Desai PJ. 2018. Rapid and efficient in vitro excision of bac sequences from herpesvirus genomes using cre-mediated recombination. J Virol Methods, 261: 67-70.
   

7. Horsburgh BC, Hubinette MM, Qiang D, MacDonald ML, Tufaro F. 1999. Allele replacement: An application that permits rapid manipulation of herpes simplex virus type 1 genomes. Gene Ther, 6: 922-930.
   

8. Hou Z, Zhou Z, Wang Z, Xiao G. 2016. Assembly of long DNA sequences using a new synthetic escherichia coli-yeast shuttle vector. Virol Sin, 31: 160-167.
   

9. Ling AL, Solomon IH, Landivar AM, Nakashima H, Woods JK, Santos A, Masud N, Fell G, Mo X, Yilmaz AS, Grant J, Zhang A, Bernstock JD, Torio E, Ito H, Liu J, Shono N, Nowicki MO, Triggs D, Halloran P, Piranlioglu R, Soni H, Stopa B, Bi WL, Peruzzi P, Chen E, Malinowski SW, Prabhu MC, Zeng Y, Carlisle A, Rodig SJ, Wen PY, Lee EQ, Nayak L, Chukwueke U, Gonzalez Castro LN, Dumont SD, Batchelor T, Kittelberger K, Tikhonova E, Miheecheva N, Tabakov D, Shin N, Gorbacheva A, Shumskiy A, Frenkel F, Aguilar-Cordova E, Aguilar LK, Krisky D, Wechuck J, Manzanera A, Matheny C, Tak PP, Barone F, Kovarsky D, Tirosh I, Suva ML, Wucherpfennig KW, Ligon K, Reardon DA, Chiocca EA. 2023. Clinical trial links oncolytic immunoactivation to survival in glioblastoma. Nature, 623: 157-166.
   

10. Oldfield LM, Grzesik P, Voorhies AA, Alperovich N, MacMath D, Najera CD, Chandra DS, Prasad S, Noskov VN, Montague MG, Friedman RM, Desai PJ, Vashee S. 2017. Genome-wide engineering of an infectious clone of herpes simplex virus type 1 using synthetic genomics assembly methods. Proc Natl Acad Sci U S A, 114: E8885-e8894.
    

11. Richards AL, Sollars PJ, Smith GA. 2016. New tools to convert bacterial artificial chromosomes to a self-excising design and their application to a herpes simplex virus type 1 infectious clone. BMC Biotechnol, 16: 64.
    

12. Russell SJ, Peng KW, Bell JC. 2012. Oncolytic virotherapy. Nat Biotechnol, 30: 658-670.
    

13. Shalhout SZ, Miller DM, Emerick KS, Kaufman HL. 2023. Therapy with oncolytic viruses: Progress and challenges. Nat Rev Clin Oncol, 20: 160-177.
    

14. Tanaka M, Kagawa H, Yamanashi Y, Sata T, Kawaguchi Y. 2003. Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: Viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo. J Virol, 77: 1382-1391.
    

15. Xiao H, Hu H, Guo Y, Li J, Zeng WB, Luo MH, Wang M, Hu Z. 2024. Efficient strategy for synthesizing vector-free and oncolytic herpes simplex type 1 viruses. ACS Synth Biol, 13: 3268-3280.
    

16. Zeng WB, Jiang HF, Gang YD, Song YG, Shen ZZ, Yang H, Dong X, Tian YL, Ni RJ, Liu Y, Tang N, Li X, Jiang X, Gao D, Androulakis M, He XB, Xia HM, Ming YZ, Lu Y, Zhou JN, Zhang C, Xia XS, Shu Y, Zeng SQ, Xu F, Zhao F, Luo MH. 2017. Anterograde monosynaptic transneuronal tracers derived from herpes simplex virus 1 strain h129. Mol Neurodegener, 12: 38.
    

Proportional views

Electronic Supplementary Material

10.1016j.virs.2026.03.003-ESM.doc